Kathryn G. Dewey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kathryn G. Dewey has a total of 571 co-authors. Here are the top co-authors by number of shared publications:
- Charles Dale Arnold
Institute for Global Nutrition and Department of Nutrition Davis CA 95616 University of California Davis
27 shared publications - Per Ashorn
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
27 shared publications - Julie Obbagy
Project Lead, NESR team; NGAD, CNPP, FNS, USDA
23 shared publications - Nancy Terry
Biomedical librarian, NESR team; National Institutes of Health Library, U.S. Department of Health and Human Services
22 shared publications - Seth Adu-Afarwuah
Department of Nutrition and Food Science, University of Ghana, Legon, Accra, Ghana
21 shared publications - Ulla Ashorn
Tampere University and Tampere University Hospital
19 shared publications
Latest Publications
- Open Access
- 28 April 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (4) , e015866
Haemoglobin concentration thresholds that discriminate functional outcomes among children aged 6–30 months in eight countries: a pooled analysis of individual participant data
Introduction: The WHO cut-offs to define anaemia among children (haemoglobin, Hb 2 for the pooled AUC analysis indicated generally low to moderate heterogeneity across studies. Conclusions: The current WHO cut-offs to define anaemia among children are in the middle to upper range of Hb values that best discriminate concurrent physical activity and development, and are in the lower range of values that best discriminate subsequent child development. Along with other types of evidence, this study provides additional evidence to inform Hb cut-offs to define anaemia among young children.
- 28 April 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (4) , e015866
Open AccessHaemoglobin concentration thresholds that discriminate functional outcomes among children aged 6–30 months in eight countries: a pooled analysis of individual participant data
Introduction: The WHO cut-offs to define anaemia among children (haemoglobin, Hb 2 for the pooled AUC analysis indicated generally low to moderate heterogeneity across studies. Conclusions: The current WHO cut-offs to define anaemia among children are in the middle to upper range of Hb values that best discriminate concurrent physical activity and development, and are in the lower range of values that best discriminate subsequent child development. Along with other types of evidence, this study provides additional evidence to inform Hb cut-offs to define anaemia among young children.
- 8 April 2026
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 123 (6) , 101310
Sustained effects of combined maternal and child small-quantity lipid–based nutrient supplements in early life on growth and developmental outcomes at preschool age: an individual participant data analysis of randomized trials in Ghana and Bangladesh
- 8 April 2026
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 123 (6) , 101310
Sustained effects of combined maternal and child small-quantity lipid–based nutrient supplements in early life on growth and developmental outcomes at preschool age: an individual participant data analysis of randomized trials in Ghana and Bangladesh
- Open Access
Efficacy of multiple micronutrient supplements during pregnancy on zinc status among pregnant women in Ghana: a randomized controlled trial
Background: Multiple micronutrient deficiencies, including zinc deficiency, remain highly prevalent among pregnant women in many low- and middle-income countries and are associated with a multitude of adverse outcomes. Objective: The objectives of this analysis were to assess the impacts of prenatal multiple micronutrient supplements (MMS) compared to iron and folic acid (IFA) supplements on maternal zinc status among pregnant women at 36 weeks gestation and assess associations with birth outcomes. Methods: We analyzed plasma zinc concentrations at baseline (< 20 weeks gestation) and late pregnancy (36 weeks gestation) from a sub-set of pregnant women randomly assigned to receive either daily MMS (containing 30 mg/d zinc) or IFA supplements (n = 125/group) in the iLiNS DYAD trial in Ghana. Gestational and infant anthropometric outcomes were measured at birth. Results: At baseline, mean + SD plasma zinc concentrations were 61.9 + 13.6 µg/dL and 16.5% of women were zinc deficient (plasma zinc concentration < 50 µg/dL). At 36 weeks gestation, mean + SD plasma zinc concentrations were lower as compared to baseline, but did not differ significantly between groups (IFA: 52.2 + 8.1 µg/dL vs. MMS: 52.9 + 9.5 µg/dL; p = 0.25). Similarly, there was no difference in the estimated prevalence of zinc deficiency between groups at 36 weeks (IFA: 43.0% vs. MMS: 38.4%, p = 0.24). There were few significant associations between maternal plasma zinc concentrations or zinc deficiency and birth outcomes. Conclusions: Daily MMS supplementation for > 16 weeks during pregnancy did not significantly increase plasma zinc concentrations, and the prevalence of zinc deficiency increased over the course of pregnancy. Other complementary interventions to address both nutritional and underlying non-nutritional causes of zinc deficiency may be necessary to improve zinc status during pregnancy in this, and other vulnerable, populations. Registry: The trial was registered as a clinical trial on ClinicalTrials.gov ( NCT00970866 ) on September 2, 2009. https://clinicaltrials.gov/study/NCT00970866 .
Open AccessEfficacy of multiple micronutrient supplements during pregnancy on zinc status among pregnant women in Ghana: a randomized controlled trial
Background: Multiple micronutrient deficiencies, including zinc deficiency, remain highly prevalent among pregnant women in many low- and middle-income countries and are associated with a multitude of adverse outcomes. Objective: The objectives of this analysis were to assess the impacts of prenatal multiple micronutrient supplements (MMS) compared to iron and folic acid (IFA) supplements on maternal zinc status among pregnant women at 36 weeks gestation and assess associations with birth outcomes. Methods: We analyzed plasma zinc concentrations at baseline (< 20 weeks gestation) and late pregnancy (36 weeks gestation) from a sub-set of pregnant women randomly assigned to receive either daily MMS (containing 30 mg/d zinc) or IFA supplements (n = 125/group) in the iLiNS DYAD trial in Ghana. Gestational and infant anthropometric outcomes were measured at birth. Results: At baseline, mean + SD plasma zinc concentrations were 61.9 + 13.6 µg/dL and 16.5% of women were zinc deficient (plasma zinc concentration < 50 µg/dL). At 36 weeks gestation, mean + SD plasma zinc concentrations were lower as compared to baseline, but did not differ significantly between groups (IFA: 52.2 + 8.1 µg/dL vs. MMS: 52.9 + 9.5 µg/dL; p = 0.25). Similarly, there was no difference in the estimated prevalence of zinc deficiency between groups at 36 weeks (IFA: 43.0% vs. MMS: 38.4%, p = 0.24). There were few significant associations between maternal plasma zinc concentrations or zinc deficiency and birth outcomes. Conclusions: Daily MMS supplementation for > 16 weeks during pregnancy did not significantly increase plasma zinc concentrations, and the prevalence of zinc deficiency increased over the course of pregnancy. Other complementary interventions to address both nutritional and underlying non-nutritional causes of zinc deficiency may be necessary to improve zinc status during pregnancy in this, and other vulnerable, populations. Registry: The trial was registered as a clinical trial on ClinicalTrials.gov ( NCT00970866 ) on September 2, 2009. https://clinicaltrials.gov/study/NCT00970866 .
- Open Access
- 11 December 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (12) , e019353
Identifying priority countries for scaling up small-quantity lipid-based nutrient supplements
Introduction: Undernutrition is a cause of nearly half of all deaths among children under 5 years old. Small-quantity lipid-based nutrient supplements (SQ-LNS) have been shown to prevent child wasting, stunting, anaemia and mortality among children 6–23 months of age in low- and middle-income countries (LMICs). Scaling up effective preventive interventions is urgent given the current global food insecurity and nutrition crisis. Method: To prioritise SQ-LNS scale-up activities, we identified countries with the highest burdens of wasting, stunting and all-cause mortality among children 6–23 months of age at the national level using the most recent national survey data including the Demographic and Health Survey and Multiple Indicator Cluster Surveys, as well as the Lives Saved Tool in LMICs. National-level estimates informed a care cascade model to assess the potential impact of SQ-LNS on all-cause mortality, stunting and wasting. We also conducted a subnational level analysis among the 20 highest burden countries with the most recent available survey data to identify the highest burden regions. Results: Our analysis identified the top 20 countries with the highest burden of the three outcomes as: Niger, South Sudan, Yemen, Sudan, Somalia, Democratic Republic of Congo, Eritrea, Nigeria, Central African Republic, Guinea, Equatorial Guinea, Chad, Papua New Guinea, Benin, Mali, Angola, Pakistan, Timor-Leste, Sierra Leone and Côte d'Ivoire, although for some countries the survey data were collected >10 years ago. Some of these countries also ranked high in population estimates of acute food insecurity. The care cascade model demonstrates that a large number of cases of stunting and wasting and deaths could be potentially averted if SQ-LNS is provided. Conclusion: Most of the top 20 countries are in Sub-Saharan Africa, with a few in South and Southeast Asia. This geographical concentration underscores the urgent need for targeted interventions in these regions to prevent child malnutrition.
- 11 December 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (12) , e019353
Open AccessIdentifying priority countries for scaling up small-quantity lipid-based nutrient supplements
Introduction: Undernutrition is a cause of nearly half of all deaths among children under 5 years old. Small-quantity lipid-based nutrient supplements (SQ-LNS) have been shown to prevent child wasting, stunting, anaemia and mortality among children 6–23 months of age in low- and middle-income countries (LMICs). Scaling up effective preventive interventions is urgent given the current global food insecurity and nutrition crisis. Method: To prioritise SQ-LNS scale-up activities, we identified countries with the highest burdens of wasting, stunting and all-cause mortality among children 6–23 months of age at the national level using the most recent national survey data including the Demographic and Health Survey and Multiple Indicator Cluster Surveys, as well as the Lives Saved Tool in LMICs. National-level estimates informed a care cascade model to assess the potential impact of SQ-LNS on all-cause mortality, stunting and wasting. We also conducted a subnational level analysis among the 20 highest burden countries with the most recent available survey data to identify the highest burden regions. Results: Our analysis identified the top 20 countries with the highest burden of the three outcomes as: Niger, South Sudan, Yemen, Sudan, Somalia, Democratic Republic of Congo, Eritrea, Nigeria, Central African Republic, Guinea, Equatorial Guinea, Chad, Papua New Guinea, Benin, Mali, Angola, Pakistan, Timor-Leste, Sierra Leone and Côte d'Ivoire, although for some countries the survey data were collected >10 years ago. Some of these countries also ranked high in population estimates of acute food insecurity. The care cascade model demonstrates that a large number of cases of stunting and wasting and deaths could be potentially averted if SQ-LNS is provided. Conclusion: Most of the top 20 countries are in Sub-Saharan Africa, with a few in South and Southeast Asia. This geographical concentration underscores the urgent need for targeted interventions in these regions to prevent child malnutrition.
- Open Access
- 26 November 2025
- Published by Elsevier in Environmental Research
- Vol. 290, 123433
Arsenic, cadmium, lead, mercury, and PFAS exposure during pregnancy or lactation and respective concentrations in human milk: Systematic review
- 26 November 2025
- Published by Elsevier in Environmental Research
- Vol. 290, 123433
Open AccessArsenic, cadmium, lead, mercury, and PFAS exposure during pregnancy or lactation and respective concentrations in human milk: Systematic review
- Open Access
- 13 August 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (Suppl 5) , e016314
Prevention of wasting and nutritional oedema: evidence gaps identified during WHO guideline development
- 13 August 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (Suppl 5) , e016314
Open AccessPrevention of wasting and nutritional oedema: evidence gaps identified during WHO guideline development
- Open Access
- 13 August 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (Suppl 5) , e016220
Addressing prevention and management of wasting and nutritional oedema in children requires an improved evidence base on resource use and cost-effectiveness of interventions
- 13 August 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (Suppl 5) , e016220
Open AccessAddressing prevention and management of wasting and nutritional oedema in children requires an improved evidence base on resource use and cost-effectiveness of interventions
- Open Access
- 16 June 2025
- Published by Elsevier in The American Journal of Clinical Nutrition
Rethinking balanced food supplementation for pregnant women: time to move beyond energy and protein
- 16 June 2025
- Published by Elsevier in The American Journal of Clinical Nutrition
Open AccessRethinking balanced food supplementation for pregnant women: time to move beyond energy and protein
- 11 March 2025
- Published by Elsevier in The Lancet
- Vol. 405 (10484) , 1033-1035
Antenatal multiple micronutrient supplements: time for alignment to support country action
- 11 March 2025
- Published by Elsevier in The Lancet
- Vol. 405 (10484) , 1033-1035
Antenatal multiple micronutrient supplements: time for alignment to support country action
- Open Access
- 16 August 2024
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 120 (4) , 814-835
Effects of prenatal small-quantity lipid-based nutrient supplements on pregnancy, birth, and infant outcomes: a systematic review and meta-analysis of individual participant data from randomized controlled trials in low- and middle-income countries
- 16 August 2024
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 120 (4) , 814-835
Open AccessEffects of prenatal small-quantity lipid-based nutrient supplements on pregnancy, birth, and infant outcomes: a systematic review and meta-analysis of individual participant data from randomized controlled trials in low- and middle-income countries